SCHEMBL2831340

SCHEMBL2831340

Cc1csc(NC(=O)Oc2nc(C)sc2NCC2CC2)n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
RAB9A P51151 2/20 0.44
SCD O00767 1/20 0.43
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
GRM5 P41594 5/20 0.40
TSHR P16473 2/20 0.40
CNR2 P34972 1/20 0.40
MEN1 O00255 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
MAPT P10636 1/20 0.40
GLA P06280 1/20 0.39
TP53 P04637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2830868 0.83 MAPT (0.46) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL2828553 0.78 PIK3C3 (0.38) GRM5HPGD
SCHEMBL2825830 0.78 RAB9A (0.44) NPC1RAB9ASCDALDH1A1SMN1; SMN2
SCHEMBL2824937 0.77 KDM4E (0.39) NPC1RAB9ASCDALDH1A1SMN1; SMN2
SCHEMBL2828836 0.77 NPC1 (0.42) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL2824596 0.76 SMARCA2 (0.43) NPC1RAB9AGRM5CASP3SENP8
SCHEMBL2830798 0.76 GRM5 (0.44) NPC1RAB9ASMN1; SMN2GRM5MAPT
SCHEMBL2828434 0.76 MAPT (0.50) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL2828498 0.76 GRM5 (0.44) NPC1RAB9ASCDALDH1A1KMT2A
SCHEMBL2829129 0.75 GRM5 (0.41) NPC1RAB9ASMN1; SMN2KMT2AGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1844044-B1 THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2010-07-21 EP claimed